Hemostasis Today

August, 2026
August 2026
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930
31  
Partha Haldar: Tenecteplase vs Alteplase in Prosthetic Valve Thrombosis
Aug 1, 2026, 05:14

Partha Haldar: Tenecteplase vs Alteplase in Prosthetic Valve Thrombosis

Partha Haldar, Epidemiologist, Additional Professor at All India Institute of Medical Sciences, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in JAMA Cardiology, adding:

“Delighted to share that our collaborative work is published in JAMA Cardiology.

Tenecteplase vs Alteplase in Mechanical Prosthetic Heart Valve Thrombosis: The TENET Randomized Clinical Trial.

In this non-inferiority trial, we showed Tenecteplase may be a safe and effective alternative to Alteplase in patients presenting with obstructive PHVT.

As an epidemiologist I contributed to the study’s design strategy, statistical analysis plan, formal analysis, and interpretation.

Grateful to my cardiology colleagues, Prof. Gautam Sharma, the PI, and the co-authors for an excellent interdisciplinary collaboration.

Congratulations to the entire team.

Looking forward to more interdisciplinary research.”

Title: Tenecteplase vs Alteplase in Mechanical Prosthetic Heart Valve Thrombosis

The TENET Randomized Clinical Trial

Authors: Gautam Sharma, Krishna Prasad Akkineni, Nayani Makkar, Asmita Shukla, Partha Haldar, Devagourou Velayoudam, Kamal Kamal, Sanjeev Kumar, Nitish Naik, Ambuj Roy, Sandeep Singh, Sandeep Seth, Rohit Bhatia

Partha Haldar: Tenecteplase vs Alteplase in Prosthetic Valve Thrombosis

Stay updated with Hemostasis Today.